» Articles » PMID: 27302963

Antiplatelet and Antithrombotic Effects of the Extract of Leaves

Overview
Specialty Pharmacology
Date 2016 Jun 16
PMID 27302963
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

has been used in traditional herbal medicine for the treatment of blood stasis and inflammation. The leaves of have been reported to exhibit various physiological activities. However, there is little information available on their antiplatelet and antithrombotic activities. Thus, the present study aimed to evaluate the effect of leaf extract (LLE) on platelet activities, coagulation and thromboembolism. In a platelet aggregation study, LLE significantly inhibited various agonist-induced platelet aggregations and . Furthermore, LLE significantly inhibited collagen-induced thromboxane A2 (TXA2) production in rat platelets. In addition, oral administration of LLE was protective in a mouse model of pulmonary thromboembolism induced by intravenous injection of a mixture of collagen and epinephrine. Interestingly, LLE did not significantly alter prothrombin time (PT) and activated partial thromboplastin time (aPTT). This study indicates that the antithrombotic effects of LLE might be due to its antiplatelet activities rather than anticoagulation. Taken together, these results suggest that LLE may be a candidate preventive and therapeutic agent in cardiovascular diseases associated with platelet hyperactivity.

Citing Articles

Phytochemical Profiling, In Vitro Biological Activities, and In-Silico Studies of : An Unexplored Plant.

Aati H, Anwar M, Al-Qahtani J, Al-Taweel A, Khan K, Aati S Antibiotics (Basel). 2022; 11(9).

PMID: 36139935 PMC: 9495161. DOI: 10.3390/antibiotics11091155.


Current update on herbal sources of antithrombotic activity-a comprehensive review.

Subramani B, Sathiyarajeswaran P Egypt J Intern Med. 2022; 34(1):26.

PMID: 35283622 PMC: 8899788. DOI: 10.1186/s43162-021-00090-9.


Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Mukherjee A, Chattopadhyay D Phytother Res. 2022; 36(5):1884-1913.

PMID: 35147268 PMC: 9111032. DOI: 10.1002/ptr.7408.


Antithrombotic Effect of the Ethanol Extract of Nakai (AGE 232).

Bravo P, Jin H, Park H, Kim M, Matsui H, Lee H Life (Basel). 2021; 11(9).

PMID: 34575088 PMC: 8465650. DOI: 10.3390/life11090939.


Therapeutic Potential of : Focus on Antioxidative and Pharmacological Properties.

Haque M, Azam S, Balakrishnan R, Akther M, Kim I Plants (Basel). 2020; 9(12).

PMID: 33322185 PMC: 7763160. DOI: 10.3390/plants9121765.


References
1.
. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348(9038):1329-39. DOI: 10.1016/s0140-6736(96)09457-3. View

2.
Johnson S . Known knowns and known unknowns: risks associated with combination antithrombotic therapy. Thromb Res. 2008; 123 Suppl 1:S7-11. DOI: 10.1016/j.thromres.2008.08.011. View

3.
Gross P, Weitz J . New antithrombotic drugs. Clin Pharmacol Ther. 2009; 86(2):139-46. DOI: 10.1038/clpt.2009.98. View

4.
Vilahur G, Badimon L . Antiplatelet properties of natural products. Vascul Pharmacol. 2013; 59(3-4):67-75. DOI: 10.1016/j.vph.2013.08.002. View

5.
Ryu K, Han H, Lee S, Jeon S, Im G, Lee B . Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res. 2009; 124(3):328-34. DOI: 10.1016/j.thromres.2009.02.010. View